Allergan Announces New Board Member: Robert A. Ingram Appointed
Allergan, Inc. announced the appointment of Robert A. Ingram to the Company's Board of Directors.
Since January 2003, Mr. Ingram has been the Vice Chairman Pharmaceuticals of GlaxoSmithKline plc, a corporation involved in the research, development, manufacturing and sale of pharmaceuticals. Prior to that, he was Chief Operating Officer and President, Pharmaceutical Operations of GlaxoSmithKline plc (January 2001 to January 2003); Chief Executive Officer of Glaxo Wellcome plc (October 1997 to December 2000); and Chairman of Glaxo Wellcome Inc., Glaxo Wellcome plc's United States subsidiary (January 1999 to December 2000). In addition to his longstanding career at Glaxo, Mr. Ingram serves on the boards of Edwards Lifesciences Corporation, Lowe's Companies, Inc., and Wachovia Corporation. He also serves as Chairman, OSI Pharmaceuticals, Inc.
Mr. Ingram received his bachelor of science degree in business administration from Eastern Illinois University. He is involved in numerous civic and professional organizations and currently serves as Chairman of the Board of Trustees of the American Cancer Society Foundation. In January 2004, Mr. Ingram was awarded the Martin Luther King, Jr. Legacy Award for International Service.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.